Press "Enter" to skip to content

Grassley Statement on Trump Health Care Transparency Announcement

November 15,2019

Washington – Senate Finance Committee Chairman Chuck Grassley
(R-Iowa) today released the following statement regarding the Trump
administration’s announcement
of two new major rules requiring more price transparency in health care.

they’ve got nothing to hide or be ashamed of, then hospitals and health
insurance companies should welcome these rules. If the price of a product
causes embarrassment or puts a company at a disadvantage, that probably means
they should lower their prices. President Trump, Secretary Azar and Administrator
Verma should all be applauded for shining a light on health care industries
that are all too often shrouded in secrecy,” Grassley said. “Being able
to compare prices online will give Americans the ability to make an informed
choice about what’s best for them and their families. I hear opponents of
transparency in health care argue that giving patients more information will
only lead to confusion and that their pricing schemes are more complicated than
a price tag. And that’s exactly the problem. These reforms are long overdue and
will force insurance companies and hospitals to be more accountable to

Trump administration’s willingness to take on these entrenched and powerful
industries is yet another sign that this president is willing to take the big
steps needed to help Americans and improve health care in this country. These
actions are in line what I’ve been working on in Congress with Sen. Durbin to require
pharmaceutical companies to disclose the price of their prescription drugs on
their TV ads. I’ve also been working with Ranking Member Wyden on bipartisan legislation
to lower the cost of prescription drugs, and a big part of that is adding
much-needed transparency to the system, particularly pharmacy benefit managers
and the pharmaceutical industry.”
has long been an advocate
for greater transparency in the health care industry. Grassley is the author of
the Physician Payments Sunshine Act, which requires public disclosure of
payments between drug companies and doctors and has introduced
legislation to apply the same disclosure rules to nurse practitioners and
physician assistants.

Go to Source

%d bloggers like this: